For Immediate Release

October 03, 2019

Media Contact

AABB Communications
Magda Yang

Transfusion Medicine and Cellular Therapy Professionals Gather in San Antonio for 2019 AABB Annual Meeting


WHAT: 2019 AABB Annual Meeting
WHEN: Saturday, Oct. 19 - Tuesday, Oct. 22, 2019
WHERE: Henry B. González Convention Center
900 E. Market Street
San Antonio, TX 78205

The 2019 AABB Annual Meeting offers cutting-edge research, technological advances, continuing education and networking opportunities for professionals in the fields of transfusion medicine and cellular therapies. REGISTER HERE to receive a complimentary press registration.

Educational sessions and discussions will include:

Under the Hood of the CAR: Progress, Practical Considerations, and Product Quality Aspects of CAR-T Cell Development – Chimeric antigen receptor (CAR) T cells are genetically modified to express a hybrid receptor combining B cell receptor antigen specificity with the function of a T cell receptor and downstream cytotoxicity of CAR-T cells towards the targeted antigen. The Food and Drug Administration (FDA) approval of CAR-T cells directed towards CD19 for acute lymphoblastic leukemia (ALL) and diffuse large B cell lymphoma (DLBCL) has encouraged continued research and development. Given the initial success, continued progress, and the vital role that the field of transfusion medicine plays in clinical development and application, this session focuses on the latest developments regarding CAR-T cell therapies. Session date and time: Sunday, Oct. 20; 8:30 - 10:00 am.

Red Blood Cell Storage: The Oxygen Paradox – Red blood cells (RBCs) are solely responsible for supplying oxygen for mitochondrial metabolism in all the tissues of the body. This critical role has led to the ubiquitous use of (RBCs) as a foundation for modern healthcare systems resulting in over 100 million units of blood prescribed globally to improve the oxygen-carrying capacity of patients. Degradation during storage reduces the ability of red blood cells to carry and to deliver oxygen and creates non-red cell by-products that are associated with adverse effects. In this session, experts will discuss opportunities to improve red cell quality and resulting patient outcomes. Session date and time: Saturday, Oct. 19, 8 am – 9:30 am.

Back to the Future: Setting up and Managing a Whole Blood Transfusion Program – Transfusion of whole blood to patients is not a new procedure and was actually the standard of care prior to the advent of component therapy. Low-titer, type O whole blood (LTOWB) is, actually, still the standard of care in the military field. LTOWB transfusions are now increasing in civilian hospitals, primarily in the resuscitation of trauma patients, but also in non-trauma patients requiring massive transfusion. This session provides examples of how blood suppliers are working with hospital transfusion services and first-responders and cooperate to set up civilian LTOWB programs. Session date and time: Tuesday, Oct. 22; 9:00 – 10:30 am.

Gender Identification Challenges and Blood Donation: Education, Regulation and Experience – How should gender identification be taken into consideration during the blood donation process? This session will explore the effect of gender identification on donor eligibility requirements and donation experience, as well as the impact of new laws and best practices. Session date and time: Monday, Oct. 21, 2 – 3:30 pm.

Review the Annual Meeting program here. At AABB’s sole discretion some sessions may be closed to the media.

Other highlights:

  • General Session will feature Yancey Strickler, co-founder and former CEO of Kickstarter. Strickler will share the story of Kickstarter, taking attendees through the experience of launching the organization and managing its growth, sharing the challenges and memorable moments from the journey. Strickler will then zoom out further on to the exciting possibilities of a future that looks beyond money and expands our concept of value to include community, purpose and sustainability.
  • Exhibit Hall opening on Saturday, Oct. 18 – featuring more than 150 exhibiting companies.

Contact the AABB Communications department via phone at +1.301.215.6569 or email for additional information. More about the meeting can be found on the AABB website.

About AABB

AABB is an international, not-for-profit association representing individuals and institutions involved in the fields of transfusion medicine and biotherapies. The association is committed to improving health through the development and delivery of standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership includes physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. AABB members are located in more than 80 countries and AABB accredits institutions in more than 50 countries.